Recent data have shown that fondaparinux, a selective factor Xa inhibitor, is noninferior to enoxaparin for short-term prevention of adverse cardiovascular outcomes in patients with non-ST-segment ...

Purpose. A possible role for fondaparinux as a bridging agent in the perioperative setting is explored. Summary. Anticoagulation guidelines provide minimal direction on the perioperative use of ...

While fondaparinux has been available for nearly a decade, its use has not been nearly as extensive as the use of LMWHs. Thus, clinical experience with this agent and outcomes data are far more ...